St. Jude Children's Research Hospital scientific director elected to Institute of Medicine

October 21, 2013

(MEMPHIS, TENN. - October 21, 2013) James R. Downing, M.D., scientific director, deputy director and executive vice president at St. Jude Children's Research Hospital, has been elected to the Institute of Medicine (IOM), a prestigious branch of the National Academy of Sciences. Downing's election brings the number of IOM members from St. Jude to six. St. Jude has one of the highest numbers of IOM members among U.S. children's hospitals.

"Dr. Downing's election to the Institute of Medicine is a great testament to his many scientific accomplishments and a great honor for St. Jude," said Dr. William E. Evans, St. Jude director and CEO. "As we continue to focus on finding cures for life-threatening diseases, Dr. Downing is among those leading the way in revealing the genetic causes of childhood cancers."

Downing is internationally recognized for his seminal contributions to the understanding of the molecular pathology of acute leukemia and the application of this information to increase the number of children cured. In 2010, he was instrumental in launching the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project, the world's largest project devoted to understanding childhood cancer.

The Pediatric Cancer Genome Project has sequenced the complete normal and cancer genomes of about 700 children and adolescents with some of the least understood and most aggressive pediatric cancers. This has already produced key discoveries related to childhood leukemias, brain tumors, central nervous system tumors and eye tumors. This project is now in a second phase to dig deeper into the genomic landscape of childhood cancers. In addition, St. Jude has undertaken a major effort to translate genomics into clinical decision-making.

Joining St. Jude in 1986 as an assistant member in pathology, Downing rose through the ranks to serve as chair of the department from 1997 to 2009. In 2004, he was appointed as the institution's executive vice president and scientific director and in 2011 as its deputy director.

Downing has traveled the globe presenting his research and has received numerous honors including the Association for Molecular Pathology Award for Excellence in Molecular Diagnostics, the American Association for Cancer Research Team Science Award and the American Association for the Advancement of Science fellowship. In 2013, he was nominated by TIME magazine for its list of the 100 Most Influential People in the World.

Downing has been published in prestigious journals including New England Journal of Medicine, Nature, Science and Cell and holds membership in numerous academic and professional societies. He earned both his undergraduate and medical degrees at the University of Michigan.

Established in 1970, the IOM is an honorific organization with more than 1,900 members and foreign associates. Each year, the full membership elects up to 70 new members and 10 foreign associates for their excellence and professional achievement in a field relevant to the IOM's mission.

Other IOM members from St. Jude are Nobel Laureate Peter Doherty, Ph.D.; director and CEO Dr. William E. Evans; Arthur Nienhuis, M.D., former St. Jude CEO; Charles Sherr, M.D., Ph.D., Howard Hughes Medical Institute Investigator and Tumor Cell Biology chair; and Mary Relling, Pharm.D., Pharmaceutical Sciences chair.
St. Jude Media Relations Contacts
Summer Freeman
(desk) 901-595-3061
(cell) 901-297-9861

Carrie Strehlau
(desk) 901-595-2295
(cell) 901-297-9875

St. Jude Children's Research Hospital

Related Medicine Articles from Brightsurf:

An ultrasonic projector for medicine
A chip-based technology that modulates intensive sound pressure profiles with high resolution opens up new possibilities for ultrasound therapy.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

How dinosaur research can help medicine
The intervertebral discs connect the vertebrae and give the spine its mobility.

Graduates of family medicine residencies are likely to enter and remain in family medicine
This study provides an overview of the characteristics of physicians who completed family medicine residency training from 1994 to 2017.

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Moving beyond 'defensive medicine'
Study shows removing liability concerns slightly increases C-section procedures during childbirth.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

Protein injections in medicine
One day, medical compounds could be introduced into cells with the help of bacterial toxins.

Study reveals complementary medicine use remains hidden to conventional medicine providers
Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine
Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to 'conventional medicine'.

Read More: Medicine News and Medicine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to